Abstract
Being overexpressed in many cancer types and related to tumor invasiveness, the activity of P5C reductase represents a promising target for cancer therapy, yet no effective inhibitors have been identified so far. Several phenyl-substituted aminomethylenebisphosphonic acids had been found to inhibit the plant enzyme in the micro- to millimolar range. The two most active compounds were previously shown to be remarkably active against human P5C reductase (PYCR1, gene ID 5831). To investigate their structure–activity relationships, the human enzyme was heterogously expressed in E. coli, affinity purified and assayed in the presence of increasing concentrations of various aminobisphosphonates differing in substituents on the phenyl ring, using either NADH or NADPH as the electron donor. Some analogues, namely aminoethylenebisphosphonates, hydroxybisphosphonates, aminophosphonates and hydroxyphosphonates, were also evaluated. Results allowed to define the chemical features required for effective inhibition. The aminobisphosphonic moiety was found essential for activity, which was enhanced by the presence of electron-withdrawing substituents on the phenyl ring, provided that an optimal steric hindrance is not exceeded. These results could open up new perspectives on the synthesis of effective inhibitors of human P5C reductase to be used in chemotherapy.